On march 25, 2024, Q32 Bio Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.59 USD | -0.70% | -8.67% | +133.83% |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
Apr. 03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
43.99 USD | +0.66% | -1.92% | 89.17B | ||
25.59 USD | -0.70% | -8.67% | 305M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+133.83% | 305M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.36% | 22.94B | |
-12.15% | 22.34B | |
-6.50% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Q32 Bio Inc. announced that it has received $42 million in funding from a group of investors